3-aminocyclopentanecarboxamides as chemokine receptor modulators

Details for Australian Patent Application No. 2009321221 (hide)

Owner Pfizer Inc.

Inventors Devraj, Rajesh Venkateswaran; Huang, Wei; Hughes, Robert Owen; Rogier Jr., Donald Joseph; Trujillo, John Isidro; Turner, Steve Ronald

Agent Allens Arthur Robinson

Pub. Number AU-A-2009321221

PCT Pub. Number WO2010/061329

Priority 61/118,053 26.11.08 US

Filing date 20 November 2009

Wipo publication date 3 June 2010

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/061329 Priority application(s): WO2010/061329

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009321240-Neck brace

2009321213-Method and apparatus for fall detection